ARRIVENT BIOPHARMA, INC. (AVBP) Operating income 2023–2025
ARRIVENT BIOPHARMA, INC. (AVBP) annual operating income history from SEC filings — each fiscal year as reported.
-$177.5MFY2025 · since FY2023: -$74.6M → -$177.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$177.5M | -88.2% |
| FY2024 | -$94.3M | -26.4% |
| FY2023 | -$74.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AVBP financial trends
AVBP RevenueAVBP Net incomeAVBP Net marginAVBP Gross profitAVBP Gross marginAVBP Operating marginAVBP Operating cash flowAVBP Free cash flowAVBP Capital expendituresAVBP Return on equityAVBP Stock buybacksAVBP Dividends paidAVBP Total assetsAVBP Total liabilitiesAVBP Shareholders’ equityAVBP overview →